entrezID,gene_symbol,biotype,bioproject,res_design,host_type,stimulator,concentration,H.P.S,baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,cell_type
107985209,ARHGEF2-AS2,lncRNA,PRJNA474093,IFN-beta stimulation vs. mock stimulation,immortalized human hepatocytes PH5CH8,IFN-beta,N.A.,12,9.74842516719051,-0.0808553016752425,0.627845875895738,-0.128782086144768,0.897530080667662,0.993439746281167,NA
107985209,ARHGEF2-AS2,lncRNA,PRJNA565586,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,100U/ml,24,22.1333479391222,-0.390645339400285,0.425440086604873,-0.918214695088421,0.358506476763357,0.922713004545899,patient-derived GBM cell lines (PDGCLs)
107985209,ARHGEF2-AS2,lncRNA,PRJNA667475,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,250U/ml,8,20.3689759475212,-0.160566337237654,0.49391295900093,-0.32509035106599,0.745112691427078,0.933906632050025,A549
107985209,ARHGEF2-AS2,lncRNA,PRJNA739760,INF-alpha2 stimulation (with DMSO) vs. mock stimulation (with DMSO),NA,IFN-alpha,1000U/ml,16,28.9383160225186,0.227311998747662,0.366898410163726,0.61955024184004,0.535553934561424,0.986418245486816,A549
107985209,ARHGEF2-AS2,lncRNA,PRJNA768480,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,N.A.,N.A.,11.1684417247908,-0.545732023745751,0.894639540946788,-0.610002127972354,0.541860397935561,0.861137939878258,A549
107985209,ARHGEF2-AS2,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,7.60640492522654,0.663502594410586,0.629237669607955,1.05445466229633,0.291674807307222,1,sigmoid colon organoid
107985209,ARHGEF2-AS2,lncRNA,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,7.60640492522654,-0.0588385838146793,0.661437870899403,-0.0889555714955849,0.929117218891255,1,sigmoid colon organoid
